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Abstract
Background: We carried out an investigation in five provinces in China to assess treatment adherence and identify
factors associated with insufficient treatment adherence in tuberculosis (TB) patients in mountainous, rural areas of
China.
Methods: In each of the five provinces, all counties with > 80% mountainous area were stratified into three
groups according to their gross domestic product. In each stratum, one county was randomly sampled. Study
subjects were sampled from all smear positive TB cases registered in 2007 in the target counties. TB patients,
village doctors, county doctors and directors of the TB prevention and control institutes were interviewed.
Insufficient medication adherence was defined as taking less than 90% of anti-TB drug doses prescribed.
Insufficient re-examination adherence was defined as having less than the recommended three sputum smear
examinations during the treatment course.
Results: A minority of patients took drugs under direct observation: on average 29% during the intensive phase of
treatment. In total, 524 TB patients were included, of whom 49 (9.4%) took less than 90% of all doses prescribed
and 92 (17.6%) did not have all sputum smear examinations, with substantial variations between the provinces. In
multivariable analysis, no direct observation of treatment during the intensive phase and the presence of adverse
events were associated both with insufficient medication adherence and insufficient re-examination adherence.
Overall, 79% of patients were adherent both to treatment and re-examinations.
Conclusions: In these remote and poor areas of China, the TB control program is not fully functioning according
to the guidelines. The majority of patients are not treated under direct observation, while direct observation by
health care staff was associated with better adherence, both to drug therapy and re-examinations. Insufficient
adherence increases the risk of unsuccessful treatment outcomes and development of drug resistance. Measures
should be taken urgently in these areas to strengthen implementation of the international Stop TB strategy.
Background
Adherence, or compliance, refers to the extent patients
correctly follow medical advice [1]. Adherence refers
both to taking drugs according to prescription and to
adherence to other recommendations such as attending
medical check-ups. Within the international tuberculosis
(TB) control strategy [2], direct observation of treatment
(DOT) was introduced to improve treatment outcomes
[3]. Non-adherence increases the risk of prolonged
infectiousness, development of drug resistance, relapse
of TB, and death [3-10]. Barriers to adherence include
poor literacy of patients on health in general and lack of
comprehension of benefits of treatment and risks of pre-
maturely stopping treatment specifically, occurrence of
side effects, and costs [11].
C h i n ar a n k ss e c o n do nt h el i s to fc o u n t r i e sw i t ht h e
highest number of yearly, incident TB cases [12]. In
2009, an estimated 1.3 million individuals in China got
TB. A recent study in Jiangsu province in China found
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prescribed doses of anti-TB treatment [13]. Another
study in Hebei province however observed that 46%
missed at least 10% of the doses [14]. Several other stu-
dies in China also indicated low treatment adherence
among sputum smear-positive pulmonary tuberculosis
patients [15-18]. However, only one province or one city
had been investigated in these previous studies. More-
over, studies in mountainous areas of China are very
limited. In rural, mountainous areas in China, limited
access to transportation, the large service area of health
clinics and village doctors, and poverty may complicate
access to health care for diagnosis and treatment of TB
even more than in other rural areas [19]. We carried
out an investigation in five provinces in China to assess
treatment adherence and identify factors associated with
insufficient treatment adherence in tuberculosis patients
in mountainous, rural areas of China. These results may
be used to develop targeted measures to improve patient
treatment adherence and hereby improve cure and
reduce development of drug resistance and recurrence
of TB.
Methods
Study population and sampling
This cross-sectional comparative study was conducted in
counties with at least 80% of the population living in
mountainous areas. Five provinces with a significant
proportion of mountainous area in their province parti-
cipated in the study: Anhui, Ningxia, Gansu, Jiangxi and
Guizhou. Situated inland astride the Yangzi (Yangtse or
Changjiang) River, Anhui is a rich agricultural land on
the fringes of the North China plain. Situated near the
geographical central northern edge, Ningxia Province
belongs more naturally to the North-Western group of
provinces. Gansu Province is the north-western corridor
into China, bounded by inhospitable, mountainous Qin-
ghai to the south-west and the Gobi desert to the
north-east, it forms the natural route for the overland
silk routes into the heartland of China. Jiangxi is a fairly
mountainous inland province with a long history. The
town of Jingdezhen is famous for its blue and white por-
celain. Guizhou is not one thing or another, it’s near the
border with Vietnam but not on the border and in the
mountains but not the high mountains, it has a some-
what transitional climate too, between the tropical and
the continental types.
Of all counties in these provinces, 17 (16%), 8 (36%),
46 (53%), 42 (42%), 75 (85%) respectively, had at least
80% of the population living in mountainous areas. Per
province, these mountainous counties were stratified in
three strata (tertiles) according to the provincial per
capita gross domestic product (GDP). Per stratum, one
county was randomly selected so that in total 15
counties, three from each of five provinces, were
included in the sample.
We calculated that with a sample size of 500, assum-
ing a rate of exposed to unexposed of 1:2 and 25%
chance of disease among the unexposed, we would be
able to demonstrate an odds ratio of minimally 2 with
alpha = 0.05 and beta = 0.10. Therefore, we aimed to
interview 35 smear-positive pulmonary TB patients per
county.
We randomly sampled smear positive cases from all
smear positive cases registered in 2007 in the target
mountainous counties. Sampling was performed in
batches until 35 cases per county had been included. In
one county in Ningxia province, 34 cases were included.
A sample of 556 individuals was necessary to include
these 524 (94%) patients. The main reason for non-par-
ticipation was individuals having migrated out of the
county for work.
Data collection
We examined which patient related factors (e.g. age and
sex), healthcare provider related factors (e.g. treatment
supervision), and socio-economic factors (e.g. local
GDP) were associated with poor adherence to anti-TB
drugs and poor adherence to smear examinations during
the treatment period.
A total of 524 TB patients were interviewed at the
county level TB institutes by county level TB staff, using
structured questionnaires on treatment adherence and
factors associated with low treatment adherence. Each
item of the questionnaire was carefully explained to the
study subjects, all the questionnaire was administered by
trained interviewers. A preliminary investigation was
carried out before formal study.
In order to assess which reasons TB physicians
thought to be associated with insufficient adherence,
structured interviews were held with the director of
each county TB dispensary, with doctors at the county
level TB dispensary, and with doctors at the township
and village level. TB dispensary doctors prescribe treat-
ment and examine patients during follow-up medical
examinations while township and village doctors moni-
tor treatment.
The same protocol was used in each province. In each
province, county level investigators were trained by the
provincial level investigators during a one day workshop
before data collection. Data collection took place
between October 2008 and January 2009, so that the
whole 2007 cohort had finished treatment.
In the standardized thrice-weekly treatment regimen
new patients should take drugs 90 times and smear-
positive retreatment patients 120 times. If there are one
or more sputum smear-positive results during treat-
ment, then treatment will be extended. The total
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were taken from the patient medication record card. A
patient was defined to have good adherence to treat-
ment if the proportion of actual doses taken of those
prescribed was at least 90%.
According to the national TB program (NTP) guide-
line, both new and retreatment patients should have
three sputum smear examinations during the treatment
course (at 2, 5, 6 after the start of treatment for new
patients and 2, 5, 8 months for retreatment patients). A
patient was defined to have good adherence to smear
re-examinations if he or she had at least three smear re-
examinations.
After completion of questionnaire investigation by the
county level staff, provincial research staff re-interviewed
10% of included patients (4 per county). In all counties,
re-interviews gave similar results.
Data analysis
Data were double entered using EpiData version 3.1, and
all statistic analyses were performed by Statistical Pack-
age for Social Sciences (SPSS), version 10.0. Chi-square
tests were used to identify associations between patient
and treatment characteristics and treatment adherence.
Separate analyses were performed for risk factors for
insufficient adherence to taking of anti-TB drugs, and
for insufficient adherence to sputum smear re-examina-
tions. To assess independent risk factors for non-adher-
ence, variables with a P-value < 0.2 in univariate analysis
were included in multivariable logistic regression mod-
els. By backward selection based on the -2 log likelihood
ratio, the final model was selected. The level of signifi-
cance was set at P < 0.05.
Ethical considerations
The investigation was carried out after written informed
consent of study participants. The study was approved
by the Ethics Committee of the national TB control
association.
Results
Study population characteristics
In the study population consisting of 524 TB patients,
the average age was 47.7 (standard deviation 17.5) years,
364 (69.5%) were males, and 427 (81.5%) were farmer.
Overall, 142 (27.1%) of the patients had no formal edu-
cation while a further 172 (32.8%) had no education
beyond primary school. The distribution of demographic
characteristics of the TB patients and characteristics of
their treatment are shown in more detail in Table 1.
Between provinces, striking differences were observed in
the proportion of patients without formal education, the
proportion of patients that were aware of the free policy
for TB diagnosis and treatment, the distances from
patients’ homes to village clinics, the proportion of
patients receiving DOT during the intensive phase, and
the proportion of patients receiving DOT during the
continuation phase (P-values < 0.001). The proportion
Table 1 Description of TB patients and their treatment per province
Anhui (n =
105)
Ningxia (n =
104)
Jiangxi (n =
105)
Guizhou (n =
105)
Ganshu (n =
105)
Total (n =
524)
participation (%) 95.2 94.2 93.3 92.4 94.3 94.2
male (%) 77.1 59.6 78.1 69.5 62.9 69.5
Mean age (SD) in years 51.5 ± 16.4 46.6 ± 17.7 44.7 ± 13.9 46.4 ± 18.8 49.1 ± 19.5 47.7 ± 17.5
previously treated patients (%) 2.9 15.4 7.6 10.5 9.5 9.2
without formal education (%) 17.1 54.8 8.6 16.2 39.0 27.1
aware of free policy for TB diagnosis and
treatment (%)
49.5 70.2 74.3 44.8 89.5 65.6
Distance from home to village clinics (%)
<1k m 42.9 37.5 29.5 5.7 53.3 33.8
1-2 km 40.0 18.3 47.6 55.2 29.5 38.2
>2k m 17.1 44.2 22.9 39.1 17.2 28.1
Distance from home to diagnostic and re-
examination center
<2 0k m 36.2 30.8 43.8 21.9 39 34.4
20-40 km 27.6 34.6 40 35.2 36.2 34.7
>4 0k m 36.2 34.6 16.2 42.9 24.8 30.9
with DOT during intensive phase (%) 26.7 43.3 31.4 9.5 35.2 29.2
with DOT during continuation phase (%) 24.8 37.5 30.5 8.6 28.6 26.0
SD = standard deviation; DOT = direct observation of treatment
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8.6% and 54.8%, and the proportion of patients that
were aware of the free policy for TB between 44.8% and
89.5%. On average, 21.8% lived more than 2 kilometers
from the village clinic and 30.9% lived more than 40
kilometers from the re-examination center. Despite dif-
ferences, the proportion of patients receiving DOT was
low in all provinces: it ranged between 9.5% and 43.3%
during the intensive phase and between 8.6% and 37.5%
in the continuation phase.
Adherence to taking of anti-TB drugs
On average, forty-nine (9.4%) of patients reported hav-
ing taken less than 90% of the drug doses prescribed.
This percentage ranged from 0% in Ningxia province
to 10.5% in Anhui province (p = 0.02) (Table 2).
Characteristics associated with poor adherence in uni-
variate analysis were province, not having a formal
education, no supervision visits by (village) doctor
during treatment, adverse effects during treatment, no
DOT during the intensive phase, no DOT during the
continuation phase, and DOT conducted outside the
patient’s home or no DOT conducted as compared to
home-based DOT (Table 2). In multivariate analysis,
independent risk factors for poor adherence were
experiencing adverse effects during treatment, no
DOT during the intensive phase and no home-based
DOT. Observation of treatment by volunteers tended
also to decrease the chance of non-adherence (p =
0.06).
Table 2 Tuberculosis patient and treatment characteristics associated with taking less than 90% of prescribed doses
of anti-TB treatment
< 90% drug
adherence
Univariate Adjusted
N n % OR 95% CI p-value OR 95% CI
Province 0.02
Anhui 105 11 10.5% 1.00
Ningxia 104 0 0% ––
Jiangxi 105 9 8.6% 0.80 0.32-2.02
Guizhou 105 22 21.0% 2.27 1.04-4.95
Ganshu 105 7 6.7% 0.61 0.23-1.64
Education level 0.04
No formal education 142 7 4.9% 1.00
At least primary school 382 42 11.0% 2.38 1.04-5.43
TB patient category 0.20
New 476 42 8.8% 1.00
Retreatment 48 7 14.6% 1.76 0.75-4.18
Adverse effects during treatment < 0.01
Yes 312 41 13.1% 1.00 1.00
No 212 8 3.8% 0.26 0.12-0.57 0.30 0.17-0.53
DOT during the intensive phase < 0.01
no DOT 241 33 13.7% 1.00 1.00
DOT by village doctors 153 5 3.3% 0.21 0.08-0.56 0.28 0.09-0.82
DOT by volunteers 130 11 8.5% 0.58 0.28-1.20 0.44 0.19-1.03
DOT during continuation phase 0.02
no DOT 253 31 12.3% 1.00
DOT by village doctors 136 4 2.9% 0.22 0.08-0.63
DOT by volunteers 135 14 10.4% 0.83 0.42-1.62
Supervision visits by (village) doctor during treatment < 0.001
Yes 462 35 7.6% 1.00
No 62 14 22.6% 3.56 1.79-7.08
Time DOT observer spends with the patient during observation of treatment 0.003
DOT at home, ≤10 minutes 181 10 5.5% 1.00 1.00
DOT at home, > 10 minutes 198 15 7.6% 1.40 0.61-3.20 2.10 0.82-5.42
DOT outside home or no DOT 145 24 16.6% 3.39 1.57-7.35 3.49 1.42-8.62
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On average, ninety-two (17.6%) patients did not have all
three re-examinations. This proportion ranged from
9.5% in Anhui province to 49.5% in Guizhou province
(p < 0.001) (Table 3).
In univariate analysis, factors associated with incom-
plete adherence to re-examinations were province, male
gender, adverse effects during treatment, return trip
costs to the diagnostic and re-examination center > 20
RMB, no supervision visits by (village) doctor during
treatment, and not having a DOT observer during treat-
ment at homeland (Table 3). Independent risk factors
associated with incomplete adherence to re-examina-
tions were province, experiencing adverse effects, and
not having a DOT observer at home.
Structured interviews with TB doctors
A total of 85 village doctors, 32 county doctors and 15
directors of county-level tuberculosis prevention and
control institutions from five provinces were inter-
viewed. TB doctors from the township/village and
county level attributed insufficient treatment adherence
to: adverse effects (50 doctors, 43%), difficulties asso-
ciated with traffic and distances in mountainous areas
(26 doctors, 22%), insufficient awareness of TB and
insufficient attention to TB symptoms (16 doctors, 14%),
migrant work (12 doctors, 10%), financial difficulties
associated with TB disease and treatment (11 doctors,
10%) and the long duration of anti-TB treatment (9 doc-
tors, 8%). The main difficulties village doctors encoun-
tered in TB work were a lack of government funding for
TB control tasks (28 doctors, 32.9%), inconvenient traf-
fic and distances in mountain areas (19 doctors, 22.4%),
low treatment adherence of patients (10 doctors, 11.8%)
low education level of patients (6 doctors, 7.1%), and
high workload (5 doctors, 5.9%). The main difficulties
county doctors encountered in their work were work-
place related: lack of government funding (n = 10, 31%),
outdated equipment (n = 7, 21.9%), and insufficient
human resources (n = 6, 18.8%). In addition, low treat-
ment adherence was mentioned relatively often as a dif-
ficulty encountered in their work (n = 7, 21.9%).
Of the 15 directors of the county-level TB prevention
and control institutions interviewed, 5 considered gov-
ernment funding for TB control to be insufficient to
meet operational needs.
Discussion
In our study population from five provinces, on average
9.4% (range: 0%-21.0%) of TB patients missed more
than 10% of the number of prescribed doses and on
average 17.6% (range: 6.7%-49.5%) of them did not go to
the CDC for all smear re-examinations. The proportion
of non-adherent patients was lowest in Ningxia province
and highest in Guizhou province. Overall, 79% of
patients complied sufficiently both to treatment and re-
examinations.
DOT aims to improve adherence in order to improve
treatment outcomes and prevent creation of drug resis-
tance. Our results show that DOT is not implemented
well in the five mountainous provinces of China
included in our study. During the intensive phase, on
average 71.2% of TB patients were not treated under
direct observation and this proportion ranged from
56.7% in Ningxia province to 90.5% in Guizhou pro-
vince. Our results is similar to the results of Sun et al
[15], they reported the majority of TB patients in rural
areas do not receive DOT from village doctors and
rarely get support, such as visits as required, from the
CTBDs or township health providers in Shandong,
China. Another study in Chongqing by Hu et al also
found DOT is not well implemented, only less than 5%
of TB patients (17/401) were observed by health staff
[18].
The patients included from Guizhou province least
often got treatment under direct observation and had
significantly lower adherence to both medication and
sputum re-examinations. Lack of treatment under direct
observation and experiencing adverse events during
treatment were the only independent risk factors which
negatively influenced adherence both to treatment and
to re-examinations in our study. Re-examinations during
treatment are important to monitor the response to the
therapy and allow identification and management of
adverse events, which in turn may help to prevent non-
adherence to therapy including default. A recent study
from China showed that many patients were not aware
of the importance of sputum re-examinations [20]. It
has been observed before that adverse events during
treatment increase the risk of non-adherence to therapy
[13,20-25]. Driver [26] studied determinants for treat-
ment interruption and found that the lack of TB disease
and treatment related knowledge were important rea-
sons for patients discontinuing treatment. Indeed, health
education has shown to improve treatment adherence
[24]. In addition, pscychosocial support from family,
friends and professionals can improve patient adherence
[24-28].
The doctors in fact mentioned that low treatment
adherence was a problem they encountered in their
work. A high workload and the remoteness of the areas
they work in may prevent them to take appropriate
actions to supervise patients and improve adherence.
Strengthening and/or increasing human resources and
improving work conditions may help improve the TB
control program. Because of the economic difficulties
and traffic problems patients experience in these remote
and poor areas of China, providing additional incentives
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during treatment
Incomplete
re-examination
Univariate Adjusted
n n (%) OR (95% CI) p-value OR (95% CI)
Province < 0.001
Anhui 105 10 9.5% 1.00 1.00
Ningxia 104 7 6.7% 0.69 0.25-1.88 0.83 0.29-2.3
Jiangxi 105 12 11.4% 1.23 0.51-2.98 1.30 0.53-3.2
Guizhou 105 52 49.5% 9.32 4.38-
19.84
11.64 5.1-26.7
Ganshu 105 11 10.5% 1.11 0.45-2.74 2.24 0.84-5.9
TB patient category 0.16
New 476 80 16.8% 1.00
Retreatment 48 12 25% 1.65 0.82-3.31
Gender 0.05
male 364 72 19.8% 1.00
female 160 20 12.5% 0.58 0.34-0.99
Age (years) 0.12
≤45 238 36 15.1% 1.00
45 -65 193 33 17.1% 1.16 0.69-1.94
> 65 93 23 24.7% 1.84 1.02-3.33
Awareness of free diagnosis and treatment policy 0.19
Yes 344 55 16.0% 1.00
No 180 37 20.6% 1.36 0.86-2.16
Patients had heard about tuberculosis before seeking care 0.10
Yes 297 45 15.2% 1.00
No 227 47 20.7% 1.46 0.93-2.30
Distance from home to village clinics 0.11
< 1 km 177 23 13% 1.00
1-2 km 200 37 18.5% 1.52 0.86-2.67
> 2 km 147 32 21.8% 1.86 1.04-3.35
Return trip costs to diagnostic and re-examination center 0.008
≤20 RMB 373 55 14.7% 1.00
> 20 RMB 151 37 24.5% 1.88 1.18-3.00
Adverse effects during treatment < 0.001
Yes 312 71 22.8% 1.00 1.00
No 212 21 9.9% 0.37 0.22-0.63 0.33 0.18-0.59
DOT during the intensive phase 0.12
no DOT 241 51 21.2% 1.00
DOT by village or town doctors 153 24 15.7% 0.69 0.41-1.18
DOT by volunteers 130 17 13.1% 0.56 0.31-1.02
DOT observer during ambulatory treatment 0.006
No DOT observer 138 44 31.90% 1.00 1.00
Family member, volunteer or other 230 31 13.50% 0.33 0.20-0.56 0.61 0.29-1.3
village doctor or township doctor 156 17 10.90% 0.26 0.14-0.49 0.33 0.18-0.63
Supervision visits by (village) doctor during treatment < 0.001
Yes 462 69 14.9% 1.00
No 62 23 37.1% 3.36 1.89-5.97
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to TB treatment like for transport may also help
improve adherence to both medical check-ups and drug
treatment.
There are three main limitations to this study. Firstly,
6% of sampled patients did not participate. It is not
clear to what extent they are different from participants
and thus to what extent this may have caused bias.
However, as the non-participation rate was low, we do
not expect that it biased our results considerably. Sec-
ondly, as patients were interviewed after treatment, they
may not have remembered all details correctly. This
may have made results more imprecise. It also is possi-
ble that patients were reluctant to admit to missing
doses of drugs, despite the explanation that the answers
would have no consequences for the patients whatso-
ever. Thirdly, we were not able to include a qualitative
study component with in depth interviews in order to
obtain insight into reasons for non-DOT and non-
compliance.
Conclusions
In these mountainous areas of China, the TB control
program is not fully functioning according to the guide-
lines. The majority of patients are not treated under
direct observation, while direct observation by health
care staff was associated with better adherence, both to
drug therapy and re-examinations. Measures should be
taken urgently in these areas to strengthen implementa-
tion of the Stop TB strategy.
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